Table 3.

Factors at time of ART initiation associated with mortality during the first 39 weeks of treatment

		Kaplan-Meier results				Cox Proportional Hazards results
	died	alive	probability of dying	log rank p- value	crude Hazard Ratio	95% CI	p-value	adjust ed Hazard Ratio	95%CI	p-value
Total	32	222	14.0
Sex
male	18	114	14.7		ref	ref
female	14	108	13.2	0.547	0.81	0.40-1.62
Age in months
< 12	27	148	17.6		2.54	0.98-6.61	0.055	2.44	0.92-6.45	0.073
≥ 12	5	74	6.4	0.047	ref	ref		ref	ref
Weight-for-age z-score a
> −2	8	103	8.1
> −3 to −2	3	53	6.5
> −4 to −3	8	34	20.3
≤ −4	13	32	30.8	0.001	1.75	1.30-2.36	0.0002	1.61	1.19-2.19	0.002
HIV RNA in copies/ml *
< 750,000	3	76	3.8		ref	ref		ref	ref
≥ 750,000	29	137	19.3	0.005	4.71	1.44- 15.48	0.011	3.22	0.97- 10.78	0.057
Pretreatment CD4%
< 15	17	78	19.1		1.97	0.99-3.95	0.055	1.72	0.84-3.50	0.136
≥ 15	15	144	11.1	0.051	ref	ref		ref	ref
TB treatment
never	16	139	11.2		ref	ref
Start before ART	8	54	13.9		1.10	0.47-2.56
Start after ART	8	29	22.4	0.321	1.88	0.80-4.41

^ain Cox proportional hazard analyses included as continues variable

^*9 children did not have a pre-treatment viral load